⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14039906 | 0.71 | — | — | |
| SCHEMBL18330879 | 0.69 | — | — | |
| SCHEMBL28026244 | 0.69 | — | — | |
| SCHEMBL5088962 | 0.67 | — | — | |
| SCHEMBL27686715 | 0.64 | — | — | |
| SCHEMBL29012420 | 0.64 | — | — | |
| SCHEMBL29012440 | 0.64 | — | — | |
| SCHEMBL17861350 | 0.61 | HDAC8 (0.39) | — | |
| SCHEMBL12559813 | 0.56 | NUDT1 (0.52) | — | |
| SCHEMBL7384422 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2711367-A1 | New spiroepoxide tetrahydrobenzo-triazoles and -imidazoles and their use as MetAP-II inhibitors | Deutsches Krebsforschungszentrum (DE) | 2014-03-26 | — | — | EP | claimed |
| WO-2023250157-A9 | INHIBITORS OF MYCOBACTERIUM TUBERCULOSIS LIPOAMIDE DEHYDROGENASE | CORNELL UNIVERSITY (US) | 2024-01-25 | — | — | WO | disclosed |
| CN-114641472-A | Bicyclo [1.1.1] pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease | 德州大学系统董事会 | 2022-06-17 | — | — | CN | disclosed |
| US-20220190260-A1 | ORGANOMETALLIC COMPOUND, COMPOSITION INCLUDING SAME, ORGANIC LIGHT-EMITTING DEVICE, AND ELECTRONIC APPARATUS | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-06-16 | — | — | US | disclosed |
| CN-107810961-B | Application of Topsentin alkaloid in resisting plant viruses and germs | 南开大学 | 2021-04-02 | — | — | CN | disclosed |
| CN-107814790-B | Topsentin derivative, preparation method thereof and application thereof in resisting plant viruses and germs | 南开大学 | 2021-03-30 | — | — | CN | disclosed |
| US-20190201352-A1 | DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | UNIV MARYLAND (US) | 2019-07-04 | — | — | US | disclosed |
| US-10226434-B2 | Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2019-03-12 | — | — | US | disclosed |
| US-20180303768-A1 | DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | UNIV MARYLAND (US) | 2018-10-25 | — | — | US | disclosed |
| US-10058516-B2 | Design, synthesis and methods of use of acyclic fleximer nucleoside analogues having anti-coronavirus activity | UNIVERSITY OF MARYLAND BALTIMORE COUNTY (US) | 2018-08-28 | — | — | US | disclosed |
| US-20180015052-A1 | DESIGN, SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXMIER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | UNIV MARYLAND (US) | 2018-01-18 | — | — | US | disclosed |
| EP-3250564-A2 | DESIGN SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXIMER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | University of Maryland, Baltimore County (US) | 2017-12-06 | — | — | EP | disclosed |
| WO-2016123318-A2 | DESIGN SYNTHESIS AND METHODS OF USE OF ACYCLIC FLEXIMER NUCLEOSIDE ANALOGUES HAVING ANTI-CORONAVIRUS ACTIVITY | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY (US) | 2016-08-04 | — | — | WO | disclosed |
| EP-2711367-A1 | New spiroepoxide tetrahydrobenzo-triazoles and -imidazoles and their use as MetAP-II inhibitors | Deutsches Krebsforschungszentrum (DE) | 2014-03-26 | — | — | EP | disclosed |
| US-20130072523-A1 | ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | VERTEX PHARMACEUTICALS INCORPORATED (US) | 2013-03-21 | — | — | US | disclosed |
| EP-2515902-A1 | ANALOGUES FOR THE TREATMENT OR PREVENTION OF FLAVIVIRUS INFECTIONS | Vertex Pharmaceuticals Incorporated (US) | 2012-10-31 | — | — | EP | disclosed |
| EP-1140828-A1 | 3-AZABICYCLO[3.1.0]HEXANE DERIVATIVES AS OPIATE RECEPTORS LIGANDS | Pfizer Limited (GB) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000039089-A1 | 3-AZABICYCLO[3.1.0.] HEXANE DERIVATIVES AS OPIATE RECEPTORS LIGANDS | PFIZER LIMITED (GB) | 2000-07-06 | — | — | WO | disclosed |